Arvinas LLC(ARVN) - 2025 Q4 - Earnings Call Transcript

Arvinas (NasdaqGS:ARVN) Q4 2025 Earnings call February 24, 2026 08:00 AM ET Company ParticipantsAndrew Saik - CFOAngela Cacace - Chief Scientific OfficerJeff Boyle - Head of Investor RelationsJonathan Miller - Managing Director of Biotech and Pharma Equity ResearchNoah Berkowitz - Chief Medical OfficerRandy Teel - President and CEOConference Call ParticipantsDaniel Bronder - AnalystSudan Loganathan - Managing Director and Equity Research AnalystTed Tenthoff - Managing Director and Senior Research AnalystTer ...